Gastrointestinal parasites cause significant welfare problems in horses; evidence-based targeted treatment programmes protect horses while reducing resistance development.
Equine parasite management exemplifies the evolution from routine calendar treatment toward evidence-based targeted treatment. Calendar dosing without monitoring has driven anthelmintic resistance while treating horses that may not need treatment and failing to identify those with high burdens. Targeted selective treatment based on faecal egg count monitoring directs treatment where it is needed, maintains anthelmintic efficacy, and protects welfare through accurate identification of high-burden animals requiring intervention.